This e-learning course discusses the changing treatment landscape in hepatocellular carcinoma (HCC) and how therapy can be optimised for the individual patient. Key clinical questions will be addressed, including;

• When and how to transition from loco-regional to systemic therapy?
• What is the role of novel systemic therapies and immunotherapy?
• What is the impact of treatment sequencing?

During the e-learning, Experts will present different patient case studies to enhance your understanding of this area.